In order to find antiosteoporotic agents from natural resources, 32 Indonesian medicinal plants were screened for their effects on osteoblast differentiation by using alkaline phosphatase (ALP) activity in MC3T3-E1 osteoblast cells as a marker. From the extract of Barleria lupulina, which showed the most potent activity, 13 iridoid glucosides, including three new ones [8-Oacetylipolamiidic acid (1), 8-O-acetyl-6-O-(p-methoxy-cis-cinnamoyl)shanzhiside (2), and 8-O-acetyl-6-O-(p-methoxy-transcinnamoyl)shanzhiside (3)] were identified. Among the 13 iridoid glucosides, ipolamiide (4) showed the most potent activity in a dose-dependent manner.
Osteoporosis is a disease characterized by reduced bone mass, quality, and strength, changes in skeletal microarchitecture, and increased fracture risk [1] . Bone is remodeled through resorption by osteoclasts and replacement by osteoblasts in a cycle of around 36 months. Thus, two types of drugs can be considered: one inhibiting the bone resorption (antiresorptive agents) and the other enhancing the bone formation (anabolic skeltal agents). Until now, antiresorptive agents, such as raloxifene, bisphosphonates, and calcitonin, were the primary pharmacological approach for osteoporosis. However, antiresorptive agents can cause the oversuppression of bone resorption to result in a hard, brittle bone with an osteopetrotic appearance and an increased risk of fracture [2] . On the other hand, anabolic skeltal agents, such as parathyloid hormone (PTH), have the potential to reduce fracture incidence by improving bone qualities in addition to increasing bone mass [3] . Thus, anabolic skeletal agents have recently broadened therapeutic options for osteoporosis drug discovery.
Bone formation progresses through distinctive developmental stages that include mitogenic growth of osteoblast precursor cells, osteoblastic differentiation, and ultimately formation of the mineralized extracellular matrix [4] . Among the stages, osteoblastic differentiation confers marked rigidity and strength on bone while still maintaining some degree of elasticity. This has suggested that stimulation of osteoblastic differentiation is an important therapeutic approach for the prevention and treatment of bone diseases such as osteoporosis.
In the course of our project to find antiosteoporotic agents from natural resources [5] [6] [7] [8] [9] , we have focused on osteoblastic differentiation and investigated the effects of 32 Indonesian medicinal plants (see Supplementary data) on osteoblast differentiation by using the alkaline phosphatase (ALP) activity in MC3T3-E1 cells as a marker [10] and found that a 70% EtOH extract of Barleria lupulina Lindl. (Acanthaceae) showed the most potent increase (49.5% increase at 50 μg/mL). In Indonesia, the leaves of B. lupulina have been traditionally used under the name of "Landik" as a diuretic and tonic, and for the treatment of fever, rheumatism, liver ailments, indigestion, constipation, jaundice, urinary infections, wounds, scabies, and swelling [11] , while the aerial part of B. lupulina was traditionally used for mental tension, diabetes, rheumatoid arthritis, and snake bites [12] . Extracts prepared from this plant were evaluated in acute and subacute models of inflammation in rats [13] , on a diabetic model of rats [14] , on central nervous system activity [15] , for antimicrobial activity against Acne vulgaris [16] , on the gastric mucosa of rats [17], and on anti-HSV-2 activity [18] . Glycosides of iridoids, phenylpropanoids, lignans, and aliphatic and benzyl alcohols have been reported [19] [20] [21] [22] . However, there is no report on antiosteoporotic activities and/or antiosteoporotic constituents. Thus, we conducted a phytochemical examination of B. lupulina to identify the active constituents.
The 70% EtOH extract of B. lupulina was sequentially fractionated into n-hexane-, EtOAc-, n-BuOH-, and H 2 O-soluble fractions. Among these, the n-hexane-and EtOAc-soluble fractions lowered the ALP activity in MC3T3-E1 cells to 57.3 ± 4.0% and 30.2 ± 2.1% of the control (ALP activity, 51.5 ± 0.4 U/mg protein), respectively, at 10 μg/mL, while the n-BuOH-and H 2 O-soluble fractions enhanced the ALP activity to 114.9 ± 5.7% and 136.1 ± 1.3%, respectively. Then, we separated the H 2 O-soluble and n-BuOH-soluble fractions by a combination of reversed-phase MPLC and pTLC techniques and obtained five compounds (1, 8-11) from the former fraction, and eight from the latter (1, 4, 5, 9-13) together with two inseparable mixtures (both 1:1) each consisting of two isomers (2 and 3, 6 and 7) ( Figure 1 ). Among the compounds isolated, compound 1 was a new iridoid glucoside, and one of the two mixtures consisted of two new iridoid glucosides (2 and 3). Other compounds identified on the basis of spectroscopic analyses were shown to be the known iridoid glucosides, ipolamiide (4) [23, 24] , ipolamiidoside (5) [23, 25] , shanzhiside (8) [26, 27] , shanzhiside methyl ester (9) [26, 28] Table 1) . On the other hand, the 13 C NMR spectrum of 1 revealed signals of an ester carbonyl (δ C 169.3, C-11), an olefin (δ C 154.0, C-3; δ C 113.5, C-4), a methyl, two methylenes, two methines, and two oxygenated quaternary carbons, together with those of an acetyl (δ C 173.2, 22.0) and a β-glucopyranosyl group (Table 1) . These were similar to those of ipolamiidoside (5) [23, 25] , an isolate from the same extract, but the 1 H and 13 C NMR spectra of 1 lacked the signals of the ester methyl (δ H 3.72, s; δ C 50.4) in 5. Thus, compound 1 was considered to be a carboxylic acid corresponding to 5, which was confirmed by the COSY, HMQC, and HMBC spectra (Figure 2a ). The HMBC correlations H-1'/C-1 and H-1/C-1' confirmed the glucosylation at C-1, while the deshielding (δ 89.0) of C-8 indicated the acetylation at C-8. On the other hand, the relative stereochemistry of 1 was determined on the basis of the ROESY correlations (Figure 2b ) to be the same as that of 5. (7) [31], respectively, obtained from the same extract as an inseparable mixture (1:1). However, the data of 2 and 3 indicated that they have a carboxylic acid and a p-methoxycinnamoyl group instead of the methyl ester and p-coumaroyl groups in 6 and 7 (Figure 3a) .
The geometry of the olefin on the p-methoxycinnamoyl group in 2 and 3 were determined to be cis and trans, The effect of the isolated compounds on the differentiation of the MC3T3-E1 cells was assayed by using ALP activity as a marker (Figure 4 ). All compounds except for 5 increased the ALP activity with different intensities in a dose-dependent manner. Among the compounds tested, ipolamiide (4) showed the strongest stimulatory effect (134.6 ± 1.5% at 25 μM), followed by 6,8-O,O-diacetylshanzhiside methyl ester (acetylbarlerin) (13, 125.9 ± 4.9% at 25 μM) and 6-O-acetylshanzhiside (12, 122.7 ± 7.1% at 25 μM). Interestingly, all the isolated compounds showed the increase of the ALP activity at low concentrations. At high concentrations, on the other hand, the activity was weakened and some compounds showed a decrease of ALP activity below that of the the control, although they did not show any cytotoxicity (data not shown). This is the same situation as ipriflavone, a phytoestrogen derivative used in the clinic [32] .
Experimental
General: Optical rotations were measured on a JASCO DIP-140 digital polarimeter. UV spectra were determined on a Shimadzu UV-160A spectrometer. HR-FABMS were recorded on a JEOL JMS-700T mass spectrometer by using glycerol as a matrix. The 1 H and 13 C NMR spectra were recorded at 400 and 100 MHz, respectively, on a JEOL JNM-LA400 spectrometer. Chemical shifts are reported in δ (ppm) using TMS as internal standard and coupling constants (J) were measured in Hz. Column chromatography (CC) was carried out on silica gel (70-230 mesh, Kanto Chemical). Medium pressure liquid chromatography (MPLC) was conducted with a Büchi MPLC apparatus on a C 18 column. Normal or reversed-phase TLC was performed on either Merck pre-coated silica gel 60F 254 plates or on Merck RP-18F 254 plates, and compounds were visualized by using ceric sulfate spray reagent. All reagents used were of analytical grades. (1) After 3 days incubation, the cells were washed with serum-free α-MEM and cultured for 3 days in α-MEM containing 1% FBS and serial dilutions of the samples. At the end of incubation, the medium was transferred to the sterilized microtube and centrifuged for 10 min at 3,000 rpm. The supernatant fluid was used for the cytotoxicity assay with lactate dehydrogenase (LDH)cytotoxicity assay kit (Wako Pure Chemical Industries), while the cells were used for the ALP assay.
8-O-Acetylipolamiidic acid
ALP activity: ALP activity was assayed according to the method of Kumegawa [33] with slight modifications. The cells were washed with PBS(-) (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) and lyzed with 250 μL of 1 mM SDS (Wako Pure Chemical Industries) in a microplate mixer for 30 min at room temp. The cell lysate was incubated with 25 μL of 40 mM disodium p-nitrophenyl phosphate (Wako Pure Chemical Industries) and 25 μL of 4 mM MgCl 2 in 0.4 M sodium carbonate buffer (pH 10.0, 25 μL) for 1 h at 37°C. After the reaction was stopped by adding 50 μL of 0.5 N NaOH solution, the amount of p-nitrophenol liberated was measured with a microplate reader at 450 nm. One unit of enzyme was defined as the activity releasing 1 nmol of p-nitrophenol per min under the standard assay condition used. ALP activity was calculated as unit per mg protein and expressed as a ratio against the ALP activity of control cells. The protein content in the cell lysate was estimated by the bicinchoninic acid (BCA) method with BSA (PIERCE, Rockford, IL, USA) as a standard.
Statistical analysis:
For all statistical analysis, data were presented as mean values ± SD. Data analysis was done using a one-way analysis of variance (ANOVA), and a p value of less than 0.05 was considered statistically significant. 
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